{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CSCs", "NRF2 pathways", "TNBC", "UA", "ferroptosis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38847277", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["94", "10.3892/or.2024.8753"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "07"}], "Journal": {"ISSN": "1791-2431", "JournalIssue": {"Volume": "52", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jul"}}, "Title": "Oncology reports", "ISOAbbreviation": "Oncol Rep"}, "ArticleTitle": "Ursolic acid inhibits the proliferation of triple\u2011negative breast cancer stem\u2011like cells through NRF2\u2011mediated ferroptosis.", "Abstract": {"AbstractText": ["Ursolic acid (UA), a pentacyclic triterpenoid that has been found in a broad variety of fruits, spices and medicinal plants, has various biological effects such as reducing inflammation, protecting cells from damage, and preserving brain function. However, its impact on ferroptosis in cancer stem\u2011like cells remains unexplored. The present study investigated the effect of UA on MDA\u2011MB\u2011231 and BT\u2011549 cell\u2011derived triple\u2011negative breast CSCs (BCSCs) and its potential ferroptosis pathway. The effects of ferroptosis on BCSCs were demonstrated by the detection of ferroptosis\u2011related indexes including the intracellular level of glutathione, malondialdehyde, reactive oxygen species and iron. The effects of UA on the biological behaviors of BCSCs were analyzed by Cell Counting Kit\u20118, stemness indexes detection and mammosphere formation assay. The mechanism of UA induction on BCSCs was explored by reverse transcription\u2011quantitative PCR and western blotting. BALB/c\u2011nude mice were subcutaneously injected with MDA\u2011MB\u2011231\u2011derived BCSCs to establish xenograft models to detect the effects of UA <i>in vivo</i>. The results revealed that BCSCs have abnormal iron metabolism and are less susceptible to ferroptosis. UA effectively reduces the stemness traits and proliferation of BCSCs in spheroids and mice models by promoting ferroptosis. It was observed that UA stabilizes Kelch\u2011like ECH\u2011associated protein 1 and suppresses nuclear factor erythroid\u2011related factor 2 (NRF2) activation. These findings suggested that the ability of UA to trigger ferroptosis through the inhibition of the NRF2 pathway could be a promising approach for treating BCSCs, potentially addressing metastasis and drug resistance in triple\u2011negative breast cancer (TNBC). This expands the clinical applications of UA and provides a theoretical basis for its use in TNBC treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China."}], "LastName": "Yang", "ForeName": "Xinhua", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Molecular Imaging, Jiading Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China."}], "LastName": "Liang", "ForeName": "Beibei", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Preparation Center, Nanchang Hongdu Hospital of TCM, Nanchang, Jiangxi 330013, P.R. China."}], "LastName": "Zhang", "ForeName": "Lisha", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, P.R. China."}], "LastName": "Zhang", "ForeName": "Mingzhu", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China."}], "LastName": "Ma", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China."}], "LastName": "Qing", "ForeName": "Lijuan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Molecular Imaging, Jiading Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China."}], "LastName": "Yang", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Molecular Imaging, Jiading Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China."}], "LastName": "Huang", "ForeName": "Gang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China."}], "LastName": "Zhao", "ForeName": "Jian", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Rep", "NlmUniqueID": "9422756", "ISSNLinking": "1021-335X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "P3M2575F3F", "NameOfSubstance": "Ursolic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "0", "NameOfSubstance": "NFE2L2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Ferroptosis"}, {"QualifierName": ["drug therapy", "pathology", "metabolism"], "DescriptorName": "Triple Negative Breast Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Triterpenes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ursolic Acid"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Houghton SC, Hankinson SE. Cancer progress and priorities: Breast cancer. Cancer Epidemiol Biomarkers Prev. 2021;30:822\u2013844. doi: 10.1158/1055-9965.EPI-20-1193.", "ArticleIdList": ["10.1158/1055-9965.EPI-20-1193", "PMC8104131", "33947744"]}, {"Citation": "Deng H, Muthupalani S, Erdman S, Liu H, Niu Z, Wang TC, Fox JG. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis. Oncoimmunology. 2022;11:2057399. doi: 10.1080/2162402X.2022.2057399.", "ArticleIdList": ["10.1080/2162402X.2022.2057399", "PMC8966989", "35371619"]}, {"Citation": "Sharma P. Biology and management of patients with triple-negative breast cancer. Oncologist. 2016;21:1050\u20131062. doi: 10.1634/theoncologist.2016-0067.", "ArticleIdList": ["10.1634/theoncologist.2016-0067", "PMC5016071", "27401886"]}, {"Citation": "Hsu JY, Chang CJ, Cheng JS. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer. Sci Rep. 2022;12:729. doi: 10.1038/s41598-021-04316-2.", "ArticleIdList": ["10.1038/s41598-021-04316-2", "PMC8760241", "35031634"]}, {"Citation": "Thiagarajan PS, Sinyuk M, Turaga SM, Mulkearns-Hubert EE, Hale JS, Rao V, Demelash A, Saygin C, China A, Alban TJ, et al. Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun. 2018;9:578. doi: 10.1038/s41467-018-02938-1.", "ArticleIdList": ["10.1038/s41467-018-02938-1", "PMC5805730", "29422613"]}, {"Citation": "Toledo-Guzm\u00e1n ME, Bigoni-Ord\u00f3\u00f1ez GD, Ib\u00e1\u00f1ez Hern\u00e1ndez M, Ortiz-S\u00e1nchez E. Cancer stem cell impact on clinical oncology. World J Stem Cells. 2018;10:183\u2013195. doi: 10.4252/wjsc.v10.i12.183.", "ArticleIdList": ["10.4252/wjsc.v10.i12.183", "PMC6306557", "30613312"]}, {"Citation": "Lin X, Wang Y, Fang K, Guo Z, Lin N, Li L. The application of nanoparticles in theranostic systems targeting breast cancer stem cells: Current progress and future challenges. Stem Cell Res Ther. 2023;14:356. doi: 10.1186/s13287-023-03584-1.", "ArticleIdList": ["10.1186/s13287-023-03584-1", "PMC10712155", "38072976"]}, {"Citation": "Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, Martin-Trevino R, Shang L, McDermott SP, Landis MD, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports. 2013;2:78\u201391. doi: 10.1016/j.stemcr.2013.11.009.", "ArticleIdList": ["10.1016/j.stemcr.2013.11.009", "PMC3916760", "24511467"]}, {"Citation": "Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u2013282. doi: 10.1038/s41580-020-00324-8.", "ArticleIdList": ["10.1038/s41580-020-00324-8", "PMC8142022", "33495651"]}, {"Citation": "Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hama\u00ef A. Ferroptosis: Cancer stem cells rely on iron until \u2018to die for\u2019 It. Cells. 2021;10:2981. doi: 10.3390/cells10112981.", "ArticleIdList": ["10.3390/cells10112981", "PMC8616391", "34831207"]}, {"Citation": "Torti SV, Torti FM. Iron and cancer: More ore to be mined. Nat Rev Cancer. 2013;13:342\u2013355. doi: 10.1038/nrc3495.", "ArticleIdList": ["10.1038/nrc3495", "PMC4036554", "23594855"]}, {"Citation": "Mai TT, Hama\u00ef A, Hienzsch A, Ca\u00f1eque T, M\u00fcller S, Wicinski J, Cabaud O, Leroy C, David A, Acevedo V, et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem. 2017;9:1025\u20131033. doi: 10.1038/nchem.2778.", "ArticleIdList": ["10.1038/nchem.2778", "PMC5890907", "28937680"]}, {"Citation": "Pandrangi SL, Raju Bagadi SA, Sinha NK, Kumar M, Dada R, Lakhanpal M, Soni A, Malvia S, Simon S, Chintamani C, et al. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: Mutation analysis. Cancer Cell Int. 2014;14:14. doi: 10.1186/1475-2867-14-14.", "ArticleIdList": ["10.1186/1475-2867-14-14", "PMC4016554", "24502646"]}, {"Citation": "Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: The critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27:436\u2013447. doi: 10.1016/j.chembiol.2020.03.011.", "ArticleIdList": ["10.1016/j.chembiol.2020.03.011", "PMC7597851", "32275864"]}, {"Citation": "Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8:372. doi: 10.1038/s41392-023-01606-1.", "ArticleIdList": ["10.1038/s41392-023-01606-1", "PMC10514338", "37735472"]}, {"Citation": "Zafar S, Khan K, Hafeez A, Irfan M, Armaghan M, Rahman AU, G\u00fcrer ES, Sharifi-Rad J, Butnariu M, Bagiu IC, et al. Ursolic acid: A natural modulator of signaling networks in different cancers. Cancer Cell Int. 2022;22:399. doi: 10.1186/s12935-022-02804-7.", "ArticleIdList": ["10.1186/s12935-022-02804-7", "PMC9741527", "36496432"]}, {"Citation": "Zhang Y, Ma X, Li H, Zhuang J, Feng F, Liu L, Liu C, Sun C. Identifying the effect of ursolic acid against triple-negative breast cancer: Coupling network pharmacology with experiments verification. Front Pharmaco. 2021;12:685773. doi: 10.3389/fphar.2021.685773.", "ArticleIdList": ["10.3389/fphar.2021.685773", "PMC8631906", "34858165"]}, {"Citation": "Zong L, Cheng G, Zhao J, Zhuang X, Zheng Z, Liu Z, Song F. Inhibitory effect of ursolic acid on the migration and invasion of doxorubicin-resistant breast cancer. Molecules. 2022;27:1282. doi: 10.3390/molecules27041282.", "ArticleIdList": ["10.3390/molecules27041282", "PMC8879026", "35209071"]}, {"Citation": "Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sci. 2021;265:118854. doi: 10.1016/j.lfs.2020.118854.", "ArticleIdList": ["10.1016/j.lfs.2020.118854", "33278391"]}, {"Citation": "Li H, Yu Y, Liu Y, Luo Z, Law BYK, Zheng Y, Huang X, Li W. Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Pharmacol Res. 2022;182:106306. doi: 10.1016/j.phrs.2022.106306.", "ArticleIdList": ["10.1016/j.phrs.2022.106306", "35714823"]}, {"Citation": "Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555\u20131577. doi: 10.1038/sj.bjc.6605642.", "ArticleIdList": ["10.1038/sj.bjc.6605642", "PMC2883160", "20502460"]}, {"Citation": "Stevens MF, Hickman JA, Langdon SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C, Gibson NW, Slack JA, et al. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res. 1987;47:5846\u20135852.", "ArticleIdList": ["3664486"]}, {"Citation": "Yates AG, Weglinski CM, Ying Y, Dunstan IK, Strekalova T, Anthony DC. Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness. J Neuroinflammation. 2022;19:8. doi: 10.1186/s12974-021-02357-y.", "ArticleIdList": ["10.1186/s12974-021-02357-y", "PMC8734544", "34991643"]}, {"Citation": "Sun N, Zhang RX, Wang Y, Huang ZJ, Han J, Bao YS, Duan WY, Dong CR, Deng GS, Zhuang G. Effects of ursolic acid on oxidative stress and inflammatory factors in a rat model of AR after PM2.5 exposure. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022;57:860\u2013867. (In Chinese)", "ArticleIdList": ["35866280"]}, {"Citation": "Innocenti F, Danesi R, Di Paolo A, Agen C, Nardini D, Bocci G, Del Tacca M. Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice. Drug Metab Dispos. 1995;23:713\u2013717.", "ArticleIdList": ["7587959"]}, {"Citation": "Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u20131072. doi: 10.1016/j.cell.2012.03.042.", "ArticleIdList": ["10.1016/j.cell.2012.03.042", "PMC3367386", "22632970"]}, {"Citation": "Tang G, Chen Y, Chen J, Chen Z, Jiang W. Deferoxamine ameliorates compressed spinal cord injury by promoting neovascularization in rats. J Mol Neurosci. 2020;70:1437\u20131444. doi: 10.1007/s12031-020-01564-1.", "ArticleIdList": ["10.1007/s12031-020-01564-1", "32383023"]}, {"Citation": "Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65:5506\u20135511. doi: 10.1158/0008-5472.CAN-05-0626.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-0626", "15994920"]}, {"Citation": "Zhong Y, Shen S, Zhou Y, Mao F, Guan J, Lin Y, Xu Y, Sun Q. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24-phenotype. Med Oncol. 2014;31:864. doi: 10.1007/s12032-014-0864-0.", "ArticleIdList": ["10.1007/s12032-014-0864-0", "24519209"]}, {"Citation": "Sandhu SS, Rouz SK, Kumar S, Swamy N, Deshmukh L, Hussain A, Haque S, Tuli HS. Ursolic acid: A pentacyclic triterpenoid that exhibits anticancer therapeutic potential by modulating multiple oncogenic targets. Biotechnol Genet Eng Rev. 2023;4:1\u201331. doi: 10.1080/02648725.2022.2162257.", "ArticleIdList": ["10.1080/02648725.2022.2162257", "36600517"]}, {"Citation": "Lee J, Hyun DH. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxidants (Basel) 2023;12:918. doi: 10.3390/antiox12040918.", "ArticleIdList": ["10.3390/antiox12040918", "PMC10135822", "37107292"]}, {"Citation": "Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS, Hubert CG, Mack SC, Jarrar AM, Karl RT, et al. Preferential iron trafficking characterizes glioblastoma stem-like cells. Cancer Cel. 2015;28:441\u2013455. doi: 10.1016/j.ccell.2015.09.002.", "ArticleIdList": ["10.1016/j.ccell.2015.09.002", "PMC4646058", "26461092"]}, {"Citation": "Hong X, Roh W, Sullivan RJ, Wong KHK, Wittner BS, Guo H, Dubash TD, Sade-Feldman M, Wesley B, Horwitz E, et al. The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 2021;11:678\u2013695. doi: 10.1158/2159-8290.CD-19-1500.", "ArticleIdList": ["10.1158/2159-8290.CD-19-1500", "PMC7933049", "33203734"]}, {"Citation": "M\u00fcller S, Sindikubwabo F, Ca\u00f1eque T, Lafon A, Versini A, Lombard B, Loew D, Wu TD, Ginestier C, Charafe-Jauffret E, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12:929\u2013938. doi: 10.1038/s41557-020-0513-5.", "ArticleIdList": ["10.1038/s41557-020-0513-5", "PMC7612580", "32747755"]}, {"Citation": "Pandrangi SL, Chittineedi P, Chalumuri SS, Meena AS, Neira Mosquera JA, S\u00e1nchez Llaguno SN, Pamuru RR, Mohiddin GJ, Mohammad A. Role of intracellular iron in switching apoptosis to ferroptosis to target therapy-resistant cancer stem cells. Molecules. 2022;27:3011. doi: 10.3390/molecules27093011.", "ArticleIdList": ["10.3390/molecules27093011", "PMC9100132", "35566360"]}, {"Citation": "Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u201398. doi: 10.1038/nchembio.2239.", "ArticleIdList": ["10.1038/nchembio.2239", "PMC5610546", "27842070"]}, {"Citation": "Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620. doi: 10.1007/s13238-020-00789-5.", "ArticleIdList": ["10.1007/s13238-020-00789-5", "PMC8310547", "33000412"]}, {"Citation": "Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u2013331. doi: 10.1016/j.cell.2013.12.010.", "ArticleIdList": ["10.1016/j.cell.2013.12.010", "PMC4076414", "24439385"]}, {"Citation": "Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u2013698. doi: 10.1038/s41586-019-1707-0.", "ArticleIdList": ["10.1038/s41586-019-1707-0", "31634899"]}, {"Citation": "Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u2013692. doi: 10.1038/s41586-019-1705-2.", "ArticleIdList": ["10.1038/s41586-019-1705-2", "PMC6883167", "31634900"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "6"}, {"Year": "2024", "Month": "5", "Day": "22"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "13", "Minute": "1"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "13", "Minute": "0"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "6", "Minute": "23"}, {"Year": "2024", "Month": "6", "Day": "6"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38847277", "PMC11184361", "10.3892/or.2024.8753", "94"]}}]}